Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP
  • Languages Spoken

  • English
  • Hindi
  • Tamil
  • Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma.
  • Gynaecological Malignancies- Carcinoma Ovary, the endometrium.
  • Haematological Malignancies -Multiple Myeloma, CML, CLL and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies- Lung Carcinoma
  • Immunotherapy
  • Precision Oncology
  • Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass
  • First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances"
  • Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck
  • malignancy http://medej.tnmgrmu.ac.in 2 (2)
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge
  • and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep
  • 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al
  • Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
  • Peush Bajpai et al.Journal of Gastrointestinal Cancer volume 50, pages943–946(2019)
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al
  • Submitted for Publication: “ Collusion: The façade and it’s implications on Total pain management in palliative care -IJPC_81_20( Indian Journal of palliative care
  • Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141patients, ICON 2009 Chennai
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid
  • Leukemia – Chronic Phase treated with Imatinib mesylate AND possible
  • correlation with electrolyte imbalances. Asia-Pacific Hematology consortium
  • held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab
  • Emtansine in Indian patients with HER2 positive unresectable locally
  • advanced or metastatic breast cancer who have received prior treatment
  • with trastuzumab and a taxane
  • A multi-centre, observational, data collection registry study to monitor the
  • routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG
  • CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY
  • INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to evaluate
  • the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as
  • a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden
  • Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient.)
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018
  • Co-Organizer of Best Of SABCS 2018 April 2018
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice ( GCP) on 1st March 2019
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019
  • Dr Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA Click Here

    Languages Spoken

  • English
  • Hindi
  • Tamil
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP
  • Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma.
  • Gynaecological Malignancies- Carcinoma Ovary, the endometrium.
  • Haematological Malignancies -Multiple Myeloma, CML, CLL and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies- Lung Carcinoma
  • Immunotherapy
  • Precision Oncology
  • Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass
  • First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances"
  • Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck
  • malignancy http://medej.tnmgrmu.ac.in 2 (2)
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge
  • and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep
  • 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al
  • Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
  • Peush Bajpai et al.Journal of Gastrointestinal Cancer volume 50, pages943–946(2019)
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al
  • Submitted for Publication: “ Collusion: The façade and it’s implications on Total pain management in palliative care -IJPC_81_20( Indian Journal of palliative care
  • Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141patients, ICON 2009 Chennai
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid
  • Leukemia – Chronic Phase treated with Imatinib mesylate AND possible
  • correlation with electrolyte imbalances. Asia-Pacific Hematology consortium
  • held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab
  • Emtansine in Indian patients with HER2 positive unresectable locally
  • advanced or metastatic breast cancer who have received prior treatment
  • with trastuzumab and a taxane
  • A multi-centre, observational, data collection registry study to monitor the
  • routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG
  • CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY
  • INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to evaluate
  • the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as
  • a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden
  • Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient.)
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018
  • Co-Organizer of Best Of SABCS 2018 April 2018
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice ( GCP) on 1st March 2019
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019
  • Dr Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA Click Here

    Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma.
  • Gynaecological Malignancies- Carcinoma Ovary, the endometrium.
  • Haematological Malignancies -Multiple Myeloma, CML, CLL and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies- Lung Carcinoma
  • Immunotherapy
  • Precision Oncology
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP
  • Languages Spoken

  • English
  • Hindi
  • Tamil
  • Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass
  • First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances"
  • Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck
  • malignancy http://medej.tnmgrmu.ac.in 2 (2)
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge
  • and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep
  • 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al
  • Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
  • Peush Bajpai et al.Journal of Gastrointestinal Cancer volume 50, pages943–946(2019)
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al
  • Submitted for Publication: “ Collusion: The façade and it’s implications on Total pain management in palliative care -IJPC_81_20( Indian Journal of palliative care
  • Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141patients, ICON 2009 Chennai
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid
  • Leukemia – Chronic Phase treated with Imatinib mesylate AND possible
  • correlation with electrolyte imbalances. Asia-Pacific Hematology consortium
  • held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab
  • Emtansine in Indian patients with HER2 positive unresectable locally
  • advanced or metastatic breast cancer who have received prior treatment
  • with trastuzumab and a taxane
  • A multi-centre, observational, data collection registry study to monitor the
  • routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG
  • CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY
  • INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to evaluate
  • the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as
  • a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden
  • Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient.)
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018
  • Co-Organizer of Best Of SABCS 2018 April 2018
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice ( GCP) on 1st March 2019
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019
  • Dr Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA Click Here

    Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass
  • First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances"
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP
  • Languages Spoken

  • English
  • Hindi
  • Tamil
  • Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma.
  • Gynaecological Malignancies- Carcinoma Ovary, the endometrium.
  • Haematological Malignancies -Multiple Myeloma, CML, CLL and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies- Lung Carcinoma
  • Immunotherapy
  • Precision Oncology
  • Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck
  • malignancy http://medej.tnmgrmu.ac.in 2 (2)
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge
  • and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep
  • 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al
  • Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
  • Peush Bajpai et al.Journal of Gastrointestinal Cancer volume 50, pages943–946(2019)
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al
  • Submitted for Publication: “ Collusion: The façade and it’s implications on Total pain management in palliative care -IJPC_81_20( Indian Journal of palliative care
  • Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141patients, ICON 2009 Chennai
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid
  • Leukemia – Chronic Phase treated with Imatinib mesylate AND possible
  • correlation with electrolyte imbalances. Asia-Pacific Hematology consortium
  • held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab
  • Emtansine in Indian patients with HER2 positive unresectable locally
  • advanced or metastatic breast cancer who have received prior treatment
  • with trastuzumab and a taxane
  • A multi-centre, observational, data collection registry study to monitor the
  • routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG
  • CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY
  • INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to evaluate
  • the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as
  • a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden
  • Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient.)
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018
  • Co-Organizer of Best Of SABCS 2018 April 2018
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice ( GCP) on 1st March 2019
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019
  • Dr Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA Click Here

    Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck
  • malignancy http://medej.tnmgrmu.ac.in 2 (2)
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge
  • and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep
  • 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al
  • Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
  • Peush Bajpai et al.Journal of Gastrointestinal Cancer volume 50, pages943–946(2019)
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al
  • Submitted for Publication: “ Collusion: The façade and it’s implications on Total pain management in palliative care -IJPC_81_20( Indian Journal of palliative care
  • Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141patients, ICON 2009 Chennai
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid
  • Leukemia – Chronic Phase treated with Imatinib mesylate AND possible
  • correlation with electrolyte imbalances. Asia-Pacific Hematology consortium
  • held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab
  • Emtansine in Indian patients with HER2 positive unresectable locally
  • advanced or metastatic breast cancer who have received prior treatment
  • with trastuzumab and a taxane
  • A multi-centre, observational, data collection registry study to monitor the
  • routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG
  • CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY
  • INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to evaluate
  • the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as
  • a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden
  • Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient.)
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018
  • Co-Organizer of Best Of SABCS 2018 April 2018
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice ( GCP) on 1st March 2019
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019
  • Dr Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA Click Here
  • Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass
  • First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances"
  • Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP
  • Languages Spoken

  • English
  • Hindi
  • Tamil
  • Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma.
  • Gynaecological Malignancies- Carcinoma Ovary, the endometrium.
  • Haematological Malignancies -Multiple Myeloma, CML, CLL and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies- Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Our Success Stories

Blogs

FAQ's

The management of breast cancer depends on several factors such as the size and location of the tumour and also if the tumour has spread to other parts of the body. Surgery with or without radiation therapy is recommended in patients with early disease. Chemotherapy and hormonal therapy are usually reserved in metastatic disease.

Drug treatment for cancer is known as chemotherapy. Chemotherapy is used alone or in combination with radiation or surgery to manage different types of cancer.

Yes. All chemotherapy has side-effects depending on the drugs given. Some common side-effects include bleeding, constipation, diarrhoea, fatigue, fever, hair loss, loss of appetite, mouth sores, nausea, pain, etc.

Osteosarcoma is a type of bone cancer usually found at the end of long bones, mostly around the knee.

App floating icon
Appointment
Health Check
Contact Us
Write to COO
Covid Vaccine
Call Us